These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17398299)

  • 1. Statins for primary prevention of coronary artery disease.
    McPherson R; Kavaslar N
    Lancet; 2007 Mar; 369(9567):1078; author reply 1079. PubMed ID: 17398299
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins for primary prevention of coronary artery disease.
    Reidenberg MM
    Lancet; 2007 Mar; 369(9567):1078; author reply 1079. PubMed ID: 17398297
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prevention and statins: is it just about going to class?
    Krasuski RA
    Mayo Clin Proc; 2008 Dec; 83(12):1313-5. PubMed ID: 19046549
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
    Ray KK; Seshasai SR; Erqou S; Sever P; Jukema JW; Ford I; Sattar N
    Arch Intern Med; 2010 Jun; 170(12):1024-31. PubMed ID: 20585067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 9. Event reduction: revisiting why we treat with statins and harnessing current evidence towards optimal therapy.
    Weart CW; Hogan RJ
    Expert Opin Pharmacother; 2011 Jan; 12(1):99-117. PubMed ID: 21108580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for primary prevention of coronary artery disease.
    Mascitelli L; Pezzetta F
    Lancet; 2007 Mar; 369(9567):1078-9; author reply 1079. PubMed ID: 17398298
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comment from tHE cardiologic-angiologic viewpoint].
    Rosemann A
    Praxis (Bern 1994); 2011 Jul; 100(14):857-8. PubMed ID: 21732298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 14. Are lipid-lowering guidelines evidence-based?
    Abramson J; Wright JM
    Lancet; 2007 Jan; 369(9557):168-9. PubMed ID: 17240267
    [No Abstract]   [Full Text] [Related]  

  • 15. Pleiotropic effects of statins in the prevention of coronary heart disease--potential side effects.
    Okuyama H; Ichikawa Y; Sun Y; Hamazaki T; Lands WE
    World Rev Nutr Diet; 2007; 96():55-66. PubMed ID: 17167280
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and dangers of statin therapy.
    Maritz FJ
    Cardiovasc J S Afr; 2002; 13(4):200-3. PubMed ID: 12389064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoproteins in acute coronary syndromes--measure, treat or disregard?
    Henkin Y; Goldbourt U; Gottlieb S
    Isr Med Assoc J; 2003 Jun; 5(6):428-33. PubMed ID: 12841017
    [No Abstract]   [Full Text] [Related]  

  • 18. Statins for prevention of stroke.
    Rosendorff C
    Lancet; 1998 Apr; 351(9108):1002-3. PubMed ID: 9546501
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
    Idzior-Waluś B
    Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of statins. Review].
    Moriguchi H; Goto Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():513-7. PubMed ID: 11347123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.